The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker

Citations

WEB OF SCIENCE

28
Citations

SCOPUS

30

초록

Background/Aim: Exosomes, derived from chronic myelogenous leukaemia (CML) cells, can be used as biomarkers and new targets for the detection of the BCR-ABL transcript. This study aimed to identify these possibilities. Materials and Methods: Human CML cell line-derived exosomes and CML-patients-derived exosomes were isolated with a size-exclusion chromatography column and ExoQuick (TM) exosome precipitation solution, respectively. Isolated exosomes were analysed by nested PCR to detect the BCR-ABL transcript. Results: Exosomes derived from the two human CML cell lines yielded a 250-bp band. RNA sequence analysis revealed 99% sequence homology with the partial mRNA for the human BCR-ABL chimeric protein. This similar to 250-bp band was also observed in the exosomes derived from patients with CML. However, only patients at the blast and accelerated phases showed the exosomal BCR-ABL transcript. Conclusion: CML-derived exosomes could act as novel targets for the detection of the BCR-ABL transcript.

키워드

Chronic myelogenous leukaemiaexosomeBCR-ABLbiomarkerCHRONIC MYELOID-LEUKEMIAACUTE LYMPHOBLASTIC-LEUKEMIABCR-ABL TRANSCRIPTSBONE-MARROWEXTRACELLULAR VESICLESTRANSPLANTATIONCANCERRECOMMENDATIONSINHIBITORSDISEASE
제목
The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker
저자
Kang, Ka-WonJung, Jik-HanHur, WoojunePark, JaenaShin, HyunkuChoi, ByeonghyeonJeong, HyesunKim, Dae SikYu, Eun SangLee, Se RyeonSung, Hwa JungKim, Seok JinChoi, Chul WonKim, Hyun KooHong, SunghoiPark, Ji-HoChoi, YeonhoPark, YongKim, Byung Soo
DOI
10.21873/anticanres.12679
발행일
2018-07
유형
Article
저널명
Anticancer Research
38
7
페이지
3935 ~ 3942